• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Schroder QEP Global Active Value Fund Z Accumulation

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Schroder
Fund Summary The Fund aims to provide capital growth and income by investing in equity and equity related securities of companies worldwide. The Fund invests at least 80% of its assets in equity or equity related securities of companies worldwide. As the Fund is index-unconstrained it is managed without reference to an index. The Fund invests in companies that have certain "Value" characteristics. Value is assessed by looking at indicators such as cash flows, dividends and earnings to identify securities which the manager believes have been undervalued by the market. The Fund may also invest in collective investment schemes, warrants and money market instruments, and hold cash. The Fund may use derivatives with the aim of achieving investment gains, reducing risk or managing the Fund more efficiently.
SEDOL code B76V8G7
ISIN GB00B76V8G74
Fund code SZQVA
Managers Justin Abercrombie
Manager Tenure 14 years
Morningstar Category Global Large-Cap Value Equity
IMA Sector Global
Fund Size £1,285 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.93%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.031
Buy Price £1.031
Price Change -1.434%
Price Date 23rd May 2019
Yield 1.99%
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 18th April 2008
Fund Status OPEN
Justin joined Schroders in 1996, was a founding member of the QEP team and led the development of the team and product range. He is the lead fund manager on all of the teams global equity strategies. Justins investment career commenced in 1993, at quantitative asset manager Pareto Partners, where he developed currency, bond and equity strategies. He holds a BSc in Business Economics from the University of Reading and an MSc (distinction) in Econometrics from London Metropolitan University.

3-year Mean Monthly Return: 1.011%

Annual Returns 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund Performance +4.60% -2.30% +35.91% -4.99% +14.88% +8.24% +16.29% -4.81% +7.90% +60.05%
Benchmark Performance
(Global Large-Cap Value Equity)
+3.71% +0.54% +30.33% -2.25% +13.33%
Time Period Cumulative Benchmark Performance
(Global Large-Cap Value Equity)
Fund Compared to Benchmark
1 day -1.43% +0.75% -2.18%
1 week -0.58% +1.82% -2.40%
1 month -3.10% -1.53% -1.57%
3 months -1.90% +1.25% -3.15%
6 months 2.89% +3.55% -0.66%
1 year -2.00% -0.91% -1.09%
3 years 40.44% +41.24% -0.79%
5 years 50.89% +54.72% -3.83%
10 years 173.12% +170.16% +2.96%
YTD 7.38% +9.02% -1.64%
Since inception 125.71% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
mini MSCI EAFE Index Futures Mar19 2.40%
Novartis AG CHE 1.08%
Roche Holding AG Dividend Right Cert. CHE 1.07%
Amgen Inc USA 1.05%
Pfizer Inc USA 1.04%
Bristol-Myers Squibb Company USA 1.03%
GlaxoSmithKline PLC GBR 1.03%
Intel Corp USA 1.02%
AbbVie Inc USA 1.01%
Cisco Systems Inc USA 0.99%
Dividend Date Per share amount Reinvestment Price
21st June 2018 0.0204 £1.0450
21st June 2017 0.0180 £1.0050
21st June 2016 0.0156 £0.7386
22nd June 2015 0.0143 £0.7457
23rd June 2014 0.0133 £0.6963